$AIAI

Weiszhaar Barbara Barton sold $308K of AIAI

Weiszhaar Barbara Barton (SVP/CAO) sold 21,178 shares of AIAI Holdings Corp (AIAI) at an average of $14.54 ($14.21–$15.62, $0.31M total) across 3 trades over 2026-06-26 to 2026-06-30.

Original reporting
SEC EDGAR · Weiszhaar Barbara Barton
Published Jul 1, 2026, 12:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 12:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIAI
Neutral
medium confidence
Mentioned
$AIAI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIAINeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale by the company’s SVP/CAO totaling ~$307.9K across three trades at $14.21–$15.62.

02

Market read

Traders may monitor for additional insider activity, but there is no accompanying fundamental catalyst in the text.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal obligations; the filing provides no stated rationale or linkage to company performance.

Relevance 4/10Novelty 5/10Timing: Filed 2026-06-30 after sales dated 2026-06-26 to 2026-06-30

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for AIAI Holdings Corp.

Company-level read

Ticker impact

$AIAINeutralMedium confidence
Context

SEC Form 4 shows SVP/CAO Weiszhaar Barbara Barton sold about $307.9K of AIAI shares in June 2026 under an open-market sale code.

Expected impact

Likely limited/short-lived impact; watch for follow-on insider activity or unusual volume around the sale window.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and a defined sale window, but it does not include new operational, financial, or regulatory information.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Because the insider did not use a 10b5-1 plan, some traders may interpret the timing as more informative than typical scheduled selling.

Key entities

  • AIAI Holdings Corp

    Subject of the Form 4 insider transaction disclosure.

  • Weiszhaar Barbara Barton

    SVP/CAO who sold shares in June 2026.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIAIMed

AIAI Holdings Announces Letter of Intent with Messier 42 LLC to Acquire Controlling Interest in Defense & National Security Company

AIAI Holdings (NASDAQ:AIAI) has signed a letter of intent to acquire a controlling stake in a defense company from Messier 42 LLC. The target is projected to generate $250M in free cash flow annually post-closing. The deal, expected to close in Q4 2026, is subject to due diligence, board approvals, and a fairness opinion.

$AIAIMed

AIAI Holdings' Constellation Network Unveils Gate AI Security Gateway and Performance Benchmarks Ahead of June Launch

AIAI Holdings said its portfolio company Constellation Network will launch Constellation Gate AI, an AI security and audit gateway, in June 2026. Constellation’s technical report evaluated prompt-injection defenses across 16 public datasets, reporting an F1 of 97.4% at a 1% false-positive rate and top rankings on 8 datasets. It also cited median response time of 53 ms.

$AIAIMed

AIAI Holdings' Constellation Network Unveils Gate AI Security Gateway and Performance Benchmarks Ahead of June Launch

AIAI Holdings said its portfolio company Constellation Network will launch Constellation Gate AI in June 2026. A technical report, according to Constellation, found Gate AI ranked first on 8 of 16 public prompt-injection benchmark datasets and top three on 4 more, with an F1 of 97.4% at a 1% false-positive rate and median response time of 53 ms.